(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 4.68% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Qiagen Nv's revenue in 2025 is $2,040,067,000.On average, 7 Wall Street analysts forecast QGEN's revenue for 2025 to be $453,091,300,480, with the lowest QGEN revenue forecast at $448,801,164,500, and the highest QGEN revenue forecast at $456,043,544,450. On average, 7 Wall Street analysts forecast QGEN's revenue for 2026 to be $477,684,698,725, with the lowest QGEN revenue forecast at $474,117,930,000, and the highest QGEN revenue forecast at $480,376,373,750.
In 2027, QGEN is forecast to generate $511,827,067,180 in revenue, with the lowest revenue forecast at $508,600,104,740 and the highest revenue forecast at $516,030,999,900.